Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Cash (2016 - 2025)

Traws Pharma's Change in Cash history spans 14 years, with the latest figure at -$2.6 million for Q4 2025.

  • Quarterly results put Change in Cash at -$2.6 million for Q4 2025, down 116.32% from a year ago — trailing twelve months through Dec 2025 was -$17.5 million (down 3488.39% YoY), and the annual figure for FY2025 was -$17.5 million, down 3488.39%.
  • Change in Cash for Q4 2025 was -$2.6 million at Traws Pharma, up from -$6.7 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $29.0 million in Q1 2021 to a low of -$11.5 million in Q3 2024.
  • The 5-year median for Change in Cash is -$4.3 million (2021), against an average of -$760250.0.
  • The sharpest move saw Change in Cash skyrocketed 617.13% in 2021, then plummeted 675.81% in 2025.
  • Year by year, Change in Cash stood at -$4.3 million in 2021, then grew by 10.49% to -$3.9 million in 2022, then dropped by 14.7% to -$4.4 million in 2023, then skyrocketed by 460.12% to $15.9 million in 2024, then crashed by 116.32% to -$2.6 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$2.6 million, -$6.7 million, and -$2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.